Healthcare Realty Trust, the Real Estate sector company, was revisited by a Wall Street analyst today. Analyst Juan C. Sanabria from BMO Capital maintained a Hold rating on the stock and has a $18.00 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Juan C. Sanabria has given his Hold rating due to a combination of factors influencing Healthcare Realty Trust’s current financial performance and future outlook. The company reported a strong second quarter in 2025, with a notable increase in same-store net operating income, attributed to effective leasing strategies. Despite a strategic reduction in dividends by 23% and the impact of asset sales, the company has managed to increase its full-year guidance, indicating a positive outlook driven by cost savings and core growth.
While the earnings per share and funds available for distribution exceeded expectations, there are still challenges such as the impact of asset disposition and the need for deleveraging. The company’s new three-year plan projects a 10% earnings growth, supported by lease-ups and cost efficiencies. Although there is potential for earnings upgrades and positive market reactions, the Hold rating reflects a cautious approach, considering both the positive developments and the existing uncertainties in the company’s financial strategy.
In another report released on July 29, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $16.00 price target.